Showing results (51-60 of 111) with videos related to
Sort By:
Pageof 12
Plos One|April 4, 2018
Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan AfricaKimberly A Powers, Matthew A Price, Etienne Karita, et al.AIDS (London, England)|October 12, 2013
Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan AfricaPauli N Amornkul, Etienne Karita, Anatoli Kamali, et al.Journal of Immunological Methods|June 15, 2011
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trialsHarry Kaltsidis, Hannah Cheeseman, Jakub Kopycinski, et al.African Journal of Laboratory Medicine|April 9, 2021
Performance of International AIDS Vaccine Initiative African clinical research laboratories in standardised ELISpot and peripheral blood mononuclear cell processing in support of HIV vaccine clinical trialsRobert K Langat, Bashir Farah, Jackton Indangasi, et al.Plos One|February 26, 2020
Evaluation of antiviral T cell responses and TSCM cells in volunteers enrolled in a phase I HIV-1 subtype C prophylactic vaccine trial in IndiaSivasankaran Munusamy Ponnan, Peter Hayes, Natalia Fernandez, et al.Virology|January 15, 2014
Dynamics of viremia in primary HIV-1 infection in Africans: insights from analyses of host and viral correlatesHeather A Prentice, Matthew A Price, Travis R Porter, et al.Frontiers in Immunology|December 19, 2022
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assayNatalia Fernandez, Peter Hayes, Julia Makinde, et al.Journal of Virology|February 1, 2013
HLA-B*57 versus HLA-B*81 in HIV-1 infection: slow and steady wins the race?Heather A Prentice, Travis R Porter, Matthew A Price, et al.The Journal of Experimental Medicine|March 25, 2009
Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipientsHayley Crawford, Wendy Lumm, Alasdair Leslie, et al.The Lancet. HIV|March 20, 2019
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trialFrances H Priddy, David J M Lewis, Huub C Gelderblom, et al.Pageof 12